Task: Answer the MCQ question.
Query: Which drug exhibits a 15.232% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a Cc1c(NC(=O)c2nn(C)c(=O)c3ccccc23)c(=O)n(-c2ccccc2)n1C
b Nc1nonc1-n1nnc(C(=O)N/N=C/c2ccc(F)cc2)c1-c1cccs1
Answer: b. Nc1nonc1-n1nnc(C(=O)N/N=C/c2ccc(F)cc2)c1-c1cccs1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Nc1nonc1-n1nnc(C(=O)N/N=C/c2ccc(F)cc2)c1-c1cccs1
Nc1nonc1-n1nnc(C(=O)N/N=C/c2ccc(F)cc2)c1-c1cccs1
1-(4-amino-1,2,5-oxadiazol-3-yl)-N-[(E)-(4-fluorophenyl)methylideneamino]-5-thiophen-2-yltriazole-4-carboxamide